Literature DB >> 22628205

Protective effects of topical application of a poorly soluble antioxidant astaxanthin liposomal formulation on ultraviolet-induced skin damage.

Susumu Hama1, Kanako Takahashi, Yuko Inai, Kanako Shiota, Ryota Sakamoto, Asako Yamada, Hiroyuki Tsuchiya, Kiyoshi Kanamura, Eiji Yamashita, Kentaro Kogure.   

Abstract

Astaxanthin (Asx) would be expected to prevent ultraviolet (UV)-induced skin damage, as it is regarded as a potent antioxidative carotenoid in biological membranes. However, it is difficult to administer Asx topically to skin because of its poor water solubility. In this study, we attempted to solve this problem by preparing liposomes containing Asx (Asx-lipo), which were dispersible in the water phase, and therefore, suitable for topical application to the skin. Asx-lipo was shown to have potent scavenging ability against chemiluminescence-dependent singlet oxygen production in the water phase. When Asx-lipo was applied to skin before UV exposure, UV-induced skin thickening was prevented. Interestingly, collagen reduction induced by UV exposure was also prevented by preadministration of Asx-lipo. In addition, topical administration of Asx-lipo containing cationic lipid inhibited melanin production in skin exposed to UV. Consequently, we succeeded in preventing UV-induced skin damage using a topical application of a liposomal formulation containing Asx.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628205     DOI: 10.1002/jps.23216

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  24 in total

1.  The protective effects of fucosterol against skin damage in UVB-irradiated human dermal fibroblasts.

Authors:  Eunson Hwang; Sang-Yong Park; Zheng-wang Sun; Heon-Sub Shin; Don-Gil Lee; Tae Hoo Yi
Journal:  Mar Biotechnol (NY)       Date:  2013-10-20       Impact factor: 3.619

2.  A Study on the Bioavailability of a Proprietary, Sustained-release Formulation of Astaxanthin.

Authors:  Doddabele Madhavi; Daniel Kagan; Supriya Seshadri
Journal:  Integr Med (Encinitas)       Date:  2018-06

3.  Potential Antioxidant and Wound Healing Effect of Nano-Liposol with High Loading Amount of Astaxanthin.

Authors:  Hyeryeon Oh; Jin Sil Lee; Daekyung Sung; Jong-Min Lim; Won Il Choi
Journal:  Int J Nanomedicine       Date:  2020-11-20

Review 4.  Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review.

Authors:  Ranga Rao Ambati; Siew Moi Phang; Sarada Ravi; Ravishankar Gokare Aswathanarayana
Journal:  Mar Drugs       Date:  2014-01-07       Impact factor: 5.118

Review 5.  Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer.

Authors:  Elena Talero; Sofía García-Mauriño; Javier Ávila-Román; Azahara Rodríguez-Luna; Antonio Alcaide; Virginia Motilva
Journal:  Mar Drugs       Date:  2015-09-30       Impact factor: 5.118

6.  Novel Self-Nano-Emulsifying Drug Delivery Systems Containing Astaxanthin for Topical Skin Delivery.

Authors:  Thellie Ponto; Gemma Latter; Giuseppe Luna; Vânia R Leite-Silva; Anthony Wright; Heather A E Benson
Journal:  Pharmaceutics       Date:  2021-05-03       Impact factor: 6.321

7.  Protective effects of astaxanthin on ConA-induced autoimmune hepatitis by the JNK/p-JNK pathway-mediated inhibition of autophagy and apoptosis.

Authors:  Jingjing Li; Yujing Xia; Tong Liu; Junshan Wang; Weiqi Dai; Fan Wang; Yuanyuan Zheng; Kan Chen; Sainan Li; Huerxidan Abudumijiti; Zheng Zhou; Jianrong Wang; Wenxia Lu; Rong Zhu; Jing Yang; Huawei Zhang; Qin Yin; Chengfen Wang; Yuqing Zhou; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

8.  Anti-Oxidative Activity of Mytiloxanthin, a Metabolite of Fucoxanthin in Shellfish and Tunicates.

Authors:  Takashi Maoka; Azusa Nishino; Hiroyuki Yasui; Yumiko Yamano; Akimori Wada
Journal:  Mar Drugs       Date:  2016-05-11       Impact factor: 5.118

9.  Synergistic antioxidative effect of astaxanthin and tocotrienol by co-encapsulated in liposomes.

Authors:  Chihiro Kamezaki; Ami Nakashima; Asako Yamada; Sachiko Uenishi; Hiroshi Ishibashi; Natsumi Shibuya; Susumu Hama; Shinzo Hosoi; Eiji Yamashita; Kentaro Kogure
Journal:  J Clin Biochem Nutr       Date:  2016-09-01       Impact factor: 3.114

10.  Astaxanthin induces migration in human skin keratinocytes via Rac1 activation and RhoA inhibition.

Authors:  Dakanda Ritto; Supita Tanasawet; Sawana Singkhorn; Wanwimol Klaypradit; Pilaiwanwadee Hutamekalin; Varomyalin Tipmanee; Wanida Sukketsiri
Journal:  Nutr Res Pract       Date:  2017-07-21       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.